We are live on ! Find out more
NGM

NGM Biopharmaceuticals, Inc. Common Stock

Delisted

NGM was delisted on the 4th of April, 2024.

Name Holding Trade Value Shares
Change
Change in
Stake
CG
1
Column Group
California
$248M +$13.3M +849,701 +6%
RCP
2
Rho Capital Partners
New York
$57.4M
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$49M -$1.36M -87,027 -3%
Vanguard Group
4
Vanguard Group
Pennsylvania
$46M +$737K +47,238 +2%
BlackRock
5
BlackRock
New York
$43.3M +$918K +58,883 +2%
SG
6
StepStone Group
California
$24M
PIM
7
Ponoi II Management
California
$19.8M
PM
8
Ponoi Management
California
$19.8M
Fidelity Investments
9
Fidelity Investments
Massachusetts
$19.4M -$436K -27,952 -2%
BI
10
BVF Inc
California
$14.6M
FLAM
11
First Light Asset Management
Minnesota
$12.5M +$3.83M +245,755 +43%
EC
12
Euclidean Capital
New York
$11.4M
Geode Capital Management
13
Geode Capital Management
Massachusetts
$10.7M +$67.7K +4,340 +0.6%
State Street
14
State Street
Massachusetts
$10.5M +$252K +16,126 +2%
Morgan Stanley
15
Morgan Stanley
New York
$8.86M +$4.47M +286,737 +98%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$8.53M +$1.96M +125,732 +29%
EC
17
EcoR1 Capital
California
$8.25M +$8.44M +541,108 New
JP Morgan Chase
18
JP Morgan Chase
New York
$8.14M -$1.38M -88,617 -14%
BC
19
Boxer Capital
California
$7.63M
WP
20
Woodline Partners
California
$7.18M +$7.35M +471,039 New
Millennium Management
21
Millennium Management
New York
$6.37M -$1.82M -116,933 -22%
Axa
22
Axa
France
$6.26M +$62 +4 +0%
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$5.37M -$1.19M -76,483 -18%
JRP
24
Jasper Ridge Partners
California
$4.75M +$15.6K +1,000 +0.3%
Charles Schwab
25
Charles Schwab
California
$4.57M +$298K +19,079 +7%